The SCORPIO-PEP trial found the drug ensitrelvir, already approved in Japan to treat people with mild to moderate COVID-19, may protect against the illness. In the study, uninfected people who began ...

A popular weight loss drug reduced the risk of COVID-19 deaths, according to a new study. The research, published Friday in the Journal of the American College of Cardiology, found during a ...

The antiviral drug molnupiravir (Lagevrio) slashed the risk of death from COVID-19 in half when given early to older adults. It also lowered all-cause deaths among older adults in the Czech ...

A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and ... Research highlights media misrepresentation of COVID-19 drug efficacy.

Wegovy, the popular obesity drug, may have yet another surprising benefit. In a large clinical trial, people taking the drug during the pandemic were less likely to die of Covid-19, researchers ...

The treatment of choice for a while. In 2020, then-President Donald Trump said he had been taking hydroxychloroquine to prevent a COVID-19 infection, despite warnings by the U.S. Food and Drug ...

This week, a scientific journal’s publisher retracted an influential study that claimed to show the drug hydroxychloroquine could treat covid-19, following years of criticism over the study’s ...

Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern Medicine Canning Thoracic Institute, published in the Journal of Cl… ...

Among people who received mRNA-1273, the incidence of symptomatic COVID-19 was 94.1% lower than among those who received placebo, investigators report in The New England Journal of Medicine.

Also Read: Atea Pharmaceuticals’ COVID-19 Treatment Flunks In Late-Stage Study, Blames’ Constantly Evolving’ Virus The efficacy evaluable patient population, which included 17% treatment non ...

"Brain fog" is one of Covid-19’s most daunting symptoms. A new study finds the equivalent of a 3- to 9-point drop in IQ depending on infection severity.

The findings appear online in the Journal of Medical Internet Research Infodemiology.. For the study, the researchers conducted an analysis of 479 reports of hydroxychloroquine, remdesivir and/or ...